Performance analysis of Context Therapeutics (CNTX)
Annual Return
Over the past 3 years, CNTX has had an average annual return of +23.70%, outperforming the benchmark SPY, which returned +22.77% annual.
Since Oct 20, 2021, CNTX has had an average annual return of -14.90%, underperforming the benchmark SPY, which returned +13.38% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +64.64% | +39.97% | -7.08% | +73.40% | -75.50% | -47.84% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +77.59% | -13.79% | +16.43% | -9.93% | +20.77% | -15.09% | +64.64% | ||||||
| 2025 | -13.02% | -2.85% | -31.03% | +41.67% | -33.41% | +13.52% | +11.36% | +15.09% | +15.36% | +12.47% | +2.76% | +31.24% | +39.97% |
| 2024 | -9.75% | +11.75% | +21.07% | -2.59% | +47.27% | +1.26% | +7.73% | +13.91% | -20.34% | +11.24% | -30.29% | -30.91% | -7.08% |
| 2023 | +62.60% | -27.33% | -27.02% | +3.36% | +49.78% | +83.88% | -31.24% | -6.35% | +46.58% | -29.82% | -19.78% | +32.93% | +73.40% |
| 2022 | -23.31% | -7.85% | +15.44% | -33.18% | +54.48% | -5.35% | -10.85% | +0.51% | -41.58% | +13.56% | +9.51% | -52.77% | -75.50% |
| 2021 | +12.94% | +19.44% | -61.33% | -47.84% |
Drawdown analysis of Context Therapeutics (CNTX)
The maximum drawdown for the CNTX was -93.53%, occurring on May 4, 2023. This drawdown has not yet recovered.
The current CNTX drawdown is -67.52%.
Since Oct 20, 2021 CNTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.53% | Oct 25, 2021 | 383 | May 4, 2023 | Ongoing | Ongoing | Ongoing |